BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25091488)

  • 1. Next generation sequencing and the management of diffuse large B-cell lymphoma: from whole exome analysis to targeted therapy.
    Jardin F
    Discov Med; 2014; 18(97):51-65. PubMed ID: 25091488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activating somatic mutations in diffuse large B-cell lymphomas: lessons from next generation sequencing and key elements in the precision medicine era.
    Bohers E; Mareschal S; Bertrand P; Viailly PJ; Dubois S; Maingonnat C; Ruminy P; Tilly H; Jardin F
    Leuk Lymphoma; 2015 May; 56(5):1213-22. PubMed ID: 25130477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma.
    Mareschal S; Dubois S; Viailly PJ; Bertrand P; Bohers E; Maingonnat C; Jaïs JP; Tesson B; Ruminy P; Peyrouze P; Copie-Bergman C; Fest T; Jo Molina T; Haioun C; Salles G; Tilly H; Lecroq T; Leroy K; Jardin F
    Genes Chromosomes Cancer; 2016 Mar; 55(3):251-67. PubMed ID: 26608593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Pathogenesis of Diffuse Large B-Cell Lymphoma.
    Dobashi A
    J Clin Exp Hematop; 2016; 56(2):71-78. PubMed ID: 27980305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activating mutations affecting the NF-kappa B pathway and EZH2-mediated epigenetic regulation are rare events in primary mediastinal large B-cell lymphoma.
    Gebauer N; Hardel TT; Gebauer J; Bernard V; Merz H; Feller AC; Rades D; Biersack H; Lehnert H; Thorns C
    Anticancer Res; 2014 Oct; 34(10):5503-7. PubMed ID: 25275047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular pathogenesis and treatment strategy in diffuse large B-cell lymphoma].
    Shimada K
    Rinsho Ketsueki; 2017; 58(10):2033-2042. PubMed ID: 28978846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of next-generation sequencing in understanding the genomic basis of diffuse large B cell lymphoma and advancing targeted therapies.
    Dubois S; Jardin F
    Expert Rev Hematol; 2016 Mar; 9(3):255-69. PubMed ID: 26652775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction and characterization of diffuse large B-cell lymphoma cell-of-origin subtypes using targeted sequencing.
    Trabucco SE; Sokol ES; Maund SL; Moore JA; Frampton GM; Albacker LA; Oestergaard MZ; Venstrom J; Sehn LH; Bolen CR
    Future Oncol; 2021 Nov; 17(31):4171-4183. PubMed ID: 34313135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targetable activating mutations are very frequent in GCB and ABC diffuse large B-cell lymphoma.
    Bohers E; Mareschal S; Bouzelfen A; Marchand V; Ruminy P; Maingonnat C; Ménard AL; Etancelin P; Bertrand P; Dubois S; Alcantara M; Bastard C; Tilly H; Jardin F
    Genes Chromosomes Cancer; 2014 Feb; 53(2):144-53. PubMed ID: 24327543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetics and molecular cytogenetics in diffuse large B-cell lymphoma (DLBCL).
    Nedomova R; Papajik T; Prochazka V; Indrak K; Jarosova M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Sep; 157(3):239-47. PubMed ID: 23132512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCL2 mutations in diffuse large B-cell lymphoma.
    Schuetz JM; Johnson NA; Morin RD; Scott DW; Tan K; Ben-Nierah S; Boyle M; Slack GW; Marra MA; Connors JM; Brooks-Wilson AR; Gascoyne RD
    Leukemia; 2012 Jun; 26(6):1383-90. PubMed ID: 22189900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translocations involving the immunoglobulin heavy chain gene locus predict better survival in gastric diffuse large B-cell lymphoma.
    Nakamura S; Ye H; Bacon CM; Goatly A; Liu H; Kerr L; Banham AH; Streubel B; Yao T; Tsuneyoshi M; Savio A; Takeshita M; Dartigues P; Ruskoné-Fourmestraux A; Matsumoto T; Iida M; Du MQ
    Clin Cancer Res; 2008 May; 14(10):3002-10. PubMed ID: 18445693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of TNF-receptor associated factor 2 correlates with poor progression-free survival time in ABC-like primary nodal diffuse large B-cell lymphomas.
    van Galen JC; Muris JJ; Giroth CP; Vos W; Ossenkoppele GJ; Meijer CJ; Oudejans JJ
    Histopathology; 2008 Apr; 52(5):578-84. PubMed ID: 18312353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-Generation Sequencing Highlights of Diffuse Large B-cell Lymphoma in a Tertiary Care Hospital in North India.
    Mamgain G; Naithani M; Patra P; Mamgain M; Morang S; Nayak J; Kumar K; Singh S; Bakliwal A; Rajoreya A; Vaniyath S; Chattopadhyay D; Chetia R; Gupta A; Dhingra G; Sundriyal D; Nath UK
    Cureus; 2022 Aug; 14(8):e28241. PubMed ID: 36158348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic aberrations of signaling pathways in lymphomagenesis: revelations from next generation sequencing studies.
    Rossi D; Ciardullo C; Gaidano G
    Semin Cancer Biol; 2013 Dec; 23(6):422-30. PubMed ID: 23665546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma.
    Ruminy P; Etancelin P; Couronné L; Parmentier F; Rainville V; Mareschal S; Bohers E; Burgot C; Cornic M; Bertrand P; Lenormand B; Picquenot JM; Jardin F; Tilly H; Bastard C
    Leukemia; 2011 Apr; 25(4):681-8. PubMed ID: 21233831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of chromatin modifiers; an emerging hallmark of germinal center B-cell lymphomas.
    Lunning MA; Green MR
    Blood Cancer J; 2015 Oct; 5(10):e361. PubMed ID: 26473533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome abnormalities in diffuse large B-cell lymphomas: analysis of 231 Chinese patients.
    Zhao X; Fan R; Lin G; Wang X
    Hematol Oncol; 2013 Sep; 31(3):127-35. PubMed ID: 23135954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing.
    Mareschal S; Pham-Ledard A; Viailly PJ; Dubois S; Bertrand P; Maingonnat C; Fontanilles M; Bohers E; Ruminy P; Tournier I; Courville P; Lenormand B; Duval AB; Andrieu E; Verneuil L; Vergier B; Tilly H; Joly P; Frebourg T; Beylot-Barry M; Merlio JP; Jardin F
    J Invest Dermatol; 2017 Sep; 137(9):1984-1994. PubMed ID: 28479318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse large B-cell lymphomas of immunoblastic type are a major reservoir for MYC-IGH translocations.
    Horn H; Staiger AM; Vöhringer M; Hay U; Campo E; Rosenwald A; Ott G; Ott MM
    Am J Surg Pathol; 2015 Jan; 39(1):61-6. PubMed ID: 25229766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.